Literature DB >> 7286266

The success rate of in vitro fertilization of human oocytes in relation to the concentrations of different hormones in follicular fluid and peripheral plasma.

H Wramsby, S Kullander, P Liedholm, G Rannevik, P Sundström, J Thorell.   

Abstract

Seventeen infertile patients were stimulated with clomiphene citrate and human chorionic gonadotrophin (hCG). During laparotomy or laparoscopy, follicles were aspirated. At least one fertilizable oocyte was obtained from 13 patients, who had normal preovulatory plasma 17 beta-estradiol (mean 2.2 nmol/l) in contrast to the 4 patients with infertilizable oocytes (mean 0.4 nmol/l). A close association was found between the success rate of fertilization and the increment of plasma progesterone from the day before to the day after the operation. If the concentrations of 17 beta-estradiol and progesterone in follicular fluid were below an arbitrary limit (17 beta-estradiol less than 500 nmol/l in association with progesterone less than 2,000 nmol/l), no oocytes could be fertilized. Apparently aspiration of oocytes and follicular fluid did not disturb ovarian steroid production during the luteal phase. The results suggest that plasma 17 beta-estradiol and progesterone determinations may serve as useful predictors for oocyte fertilizability in an in vitro system, following clomiphene-hCG stimulation and multiple oocyte recovery.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7286266     DOI: 10.1016/s0015-0282(16)45791-2

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  14 in total

1.  Clinical experience in an in vitro fertilization and embryo replacement program of a new method for analysis of urinary estrogens.

Authors:  T Hillensjö; C Chari; K Hammarberg; L Nilsson; P O Janson; A Sjögren; M Wikland
Journal:  J Endocrinol Invest       Date:  1987-02       Impact factor: 4.256

2.  A short luteal phase in cycles stimulated with clomiphene and human menopausal gonadotropin for in vitro fertilization.

Authors:  T Laatikainen; H Kurunmäki; A Koskimies
Journal:  J In Vitro Fert Embryo Transf       Date:  1988-02

3.  Hormone release from cultured luteinized-granulosa cells mimics differences seen in vivo in patients undergoing IVF-ET.

Authors:  S D Prien; M S Canez; R H Messer
Journal:  J Assist Reprod Genet       Date:  1995-03       Impact factor: 3.412

4.  Virus p30-related protein in follicular fluids and C virus-like particles on the cell membrane of the human oocyte.

Authors:  B O Nilsson; E Larsson; P Sundström
Journal:  J In Vitro Fert Embryo Transf       Date:  1986-10

5.  Immediate versus delayed progesterone supplementation in gamete intrafallopian transfer (GIFT).

Authors:  S Y Chang; Y K Soong; M Y Chang; D Y Hsiu
Journal:  J In Vitro Fert Embryo Transf       Date:  1989-10

6.  Relationship between the steroid and prolactin concentration in follicular fluid and the maturation and fertilization of human oocytes.

Authors:  A Reinthaller; J Deutinger; P Riss; E Müller-Tyl; F Fischl; C Bieglmayer; H Janisch
Journal:  J In Vitro Fert Embryo Transf       Date:  1987-08

7.  Human oocytes express murine retroviral equivalents.

Authors:  B O Nilsson; P O Kättström; P Sundström; P Jaquemin; E Larsson
Journal:  Virus Genes       Date:  1992-08       Impact factor: 2.332

8.  Hormonal parameters in follicular fluid and the fertilization rate of in vitro cultured oocytes.

Authors:  A Reinthaller; J Deutinger; C Bieglmayer; P Riss; E Müller-Tyl; F Fischl; H Janisch
Journal:  Arch Gynecol       Date:  1987

9.  Effect of human follicular fluids from pregnant and nonpregnant patients on the development of mouse zygotes in vitro.

Authors:  D W Richards; P Quinn; B A Stone; R P Marrs
Journal:  J In Vitro Fert Embryo Transf       Date:  1990-02

10.  Effects of prolactin during preincubation of mouse spermatozoa on fertilizing capacity in vitro.

Authors:  A Fukuda; C Mori; H Hashimoto; Y Noda; T Mori; K Hoshino
Journal:  J In Vitro Fert Embryo Transf       Date:  1989-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.